nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.21682/2311-1267-2020-7-1-75-81nodgo-577Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL CASESВрожденная инфантильная фибросаркома мягких тканей грудной стенки слева (описание клинического случая и обзор литературы)Congenital infantile fibrosarcoma of soft tissues of the chest wall on the left (description of the clinical case and literature review)https://orcid.org/0000-0002-7846-3473СагоянГ. Б.SagoyanG. B.

Гарик Барисович Сагоян, врач-детский онколог

SPIN-код: 6304-0159

115478, Москва, Каширское шоссе, 23

Pediatric Oncologist

SPIN-code: 6304-0159

23 Kashirskoe Shosse, Moscow, 115478, Russia

g.sagojan@ronc.ruhttps://orcid.org/0000-0002-1016-539XРубанскаяМ. В.RubanskayaM. V.

к.м.н., старший научный сотрудник 2-го хирургического отделения 

115478, Москва, Каширское шоссе, 23

Cand. of Sci. (Med.), Researcher and Pediatric Oncologist Department of Surgery No. 2  

23 Kashirskoe Shosse, Moscow, 115478, Russia

marishvecova@yandex.ruhttps://orcid.org/0000-0002-3225-1109КеримовП. А.KerimovP. A.

д.м.н., ведущий научный сотрудник 2-го хирургического отделения 

115478, Москва, Каширское шоссе, 23

Dr. of Sci. (Med.), Leading Researcher Department of Surgery No. 2

23 Kashirskoe Shosse, Moscow, 115478, Russia

polad73@mail.ruhttps://orcid.org/0000-0001-5256-2193КапковаО. А.KapkovaO. A.

врач-детский онколог 2-го хирургического отделения 

115478, Москва, Каширское шоссе, 23

Pediatric Oncologist Department of Surgery No. 2 

23 Kashirskoe Shosse, Moscow, 115478, Russia

onkodoc@yandex.ruhttps://orcid.org/0000-0001-8278-0693РубанскийМ. А.RubanskiyM. A.

к.м.н., врач-детский хирург 2-го хирургического отделения 

115478, Москва, Каширское шоссе, 23

Cand. of Sci. (Med.), Pediatric Surgeon Department of Surgery No. 2

23 Kashirskoe Shosse, Moscow, 115478, Russia

mrubansky@ya.ruhttps://orcid.org/0000-0002-7439-4431ШевцовД. В.ShevtsovD. V.

врач-детский онколог 2-го хирургического отделения 

115478, Москва, Каширское шоссе, 23

Pediatric Oncologist Department of Surgery No. 2

23 Kashirskoe Shosse, Moscow, 115478, Russia

denis.shevtsov86@gmail.comhttps://orcid.org/0000-0002-5489-1879СулеймановаА. М.SuleymanovaA. M.

врач-детский онколог 

115478, Москва, Каширское шоссе, 23

Pediatric Oncologist

23 Kashirskoe Shosse, Moscow, 115478, Russia

a.sulejmanova@ronc.ruhttps://orcid.org/0000-0002-5913-3604ПименовР. И.PimenovR. I.

врач-детский онколог 2-го хирургического отделения 

115478, Москва, Каширское шоссе, 23

Pediatric Oncologist Department of Surgery No. 2

23 Kashirskoe Shosse, Moscow, 115478, Russia

onco@list.ruhttps://orcid.org/0000-0001-9774-8039ТёмныйА. С. TemnyyA. S.

врач-детский хирург 2-го хирургического отделения 

115478, Москва, Каширское шоссе, 23

Pediatric Surgeon Department of Surgery No. 2

23 Kashirskoe Shosse, Moscow, 115478, Russia

krooyk93@gmail.comhttps://orcid.org/0000-0001-7805-5616МатинянН. В.MatinyanN. V.

д.м.н., заведующая отделением анестезиологии-реанимации 

115478, Москва, Каширское шоссе, 23

Dr. of Sci. (Med.), Head of the Department of Anesthesiology and Resuscitatio; Professor Department of Pediatric Anesthesiology and Intensive Care of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

23 Kashirskoe Shosse, Moscow, 115478, Russia

n9031990633@yandex.ruhttps://orcid.org/0000-0001-7630-7496МихайловаЕ. В.MikhailovaE. V.

к.м.н., заведующая рентгенодиагностическим отделением отдела лучевых методов диагностики и лечения опухолей 

SPIN-код: 2880-1263

115478, Москва, Каширское шоссе, 23

Cand. of Sci. (Med.), Head of the Department of Radiology of the Department of Radiation Methods for the Diagnosis and Treatment of Tumors

SPIN-code: 2880-1263

23 Kashirskoe Shosse, Moscow, 115478, Russia

elena_1357@mail.ruhttps://orcid.org/0000-0001-7309-1650КазанцевА. П.KazantsevA. P.

д.м.н., заведующий 2-м хирургическим отделением 

115478, Москва, Каширское шоссе, 23

Dr. of Sci. (Med.), Head of the Department of Surgery No. 2

23 Kashirskoe Shosse, Moscow, 115478, Russia

oncoanat@mail.ruhttps://orcid.org/0000-0001-6131-1783ВарфоломееваС. Р.VarfolomeevaS. R.

д.м.н., профессор, заместитель директора по научной и лечебной работе – директор НИИ детской онкологии и гематологии аппарата управления НМИЦ онкологии им. Н.Н. Блохина, исполнительный директор РОО НОДГО

115478, Москва, Каширское шоссе, 23

Dr. of Sci. (Med.), Professor, Deputy Director for Research and Clinical Work – Director of the Research Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Executive Director of Regional Public Organization National Society of Pediatric Hematologists and Oncologists

23 Kashirskoe Shosse, Moscow, 115478, Russia

s.varfolomeeva@ronc.ruНИИ детской онкологии и гематологии ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава РоссииРоссияResearch Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of RussiaRussian Federation202002032020717581Copyright © Сагоян Г.Б., Рубанская М.В., Керимов П.А., Капкова О.А., Рубанский М.А., Шевцов Д.В., Сулейманова А.М., Пименов Р.И., Тёмный А.С., Матинян Н.В., Михайлова Е.В., Казанцев А.П., Варфоломеева С.Р., 20202020Сагоян Г.Б., Рубанская М.В., Керимов П.А., Капкова О.А., Рубанский М.А., Шевцов Д.В., Сулейманова А.М., Пименов Р.И., Тёмный А.С., Матинян Н.В., Михайлова Е.В., Казанцев А.П., Варфоломеева С.Р.Sagoyan G.B., Rubanskaya M.V., Kerimov P.A., Kapkova O.A., Rubanskiy M.A., Shevtsov D.V., Suleymanova A.M., Pimenov R.I., Temnyy A.S., Matinyan N.V., Mikhailova E.V., Kazantsev A.P., Varfolomeeva S.R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/577

Инфантильная фибросаркома (ИФ) – редкая саркома мягких тканей, возникающая с частотой 1 % всех случаев злокачественных новообразований у детей на первом году жизни. ИФ чаще всего поражает мягкие ткани верхних и нижних конечностей. К редким локализациям относят туловище, область головы и шеи и желудочно-кишечный тракт. В статье описан редкий клинический случай врожденной ИФ мягких тканей грудной стенки у новорожденного, а также литературный обзор.

Infantile fibrosarcoma (IF) is a rare soft tissue sarcoma that occurs with a frequency of 1% of all cases of malignant neoplasms in children in the first year of life. IF most often affects the soft tissues of the upper and lower extremities. Rare localizations include the trunk, the head and neck, and the gastrointestinal tract. The article describes a rare clinical case of congenital IF of soft tissues of the chest wall in a newborn, as well as a literature review.

инфантильная фибросаркомадетская онкологияредкие опухолидетиinfantile fibrosarcomapediatric oncologyrare tumorschildrenReferencesKaatsch P., Spix C. German Childhood Cancer Registry – Annual Report 2015 (1980–2014). Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), at the University Medical Center of the Johannes Gutenberg University Mainz, 2015.Kaatsch P., Spix C. German Childhood Cancer Registry – Annual Report 2015 (1980–2014). Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), at the University Medical Center of the Johannes Gutenberg University Mainz, 2015.Cecchetto G., Carli M., Alaggio R., Dall’Igna P., Bisogno G., Scarzello G., Zanetti I., Durante G., Inserra A., Siracusa F., Guglielmi M.; Italian Cooperative Group. Fibrosarcoma in pediatric patients: results of the Italian cooperative group studies (1979–1995). J Surg Oncol 2001;78:225–31. doi: 10.1002/jso.1157.Cecchetto G., Carli M., Alaggio R., Dall’Igna P., Bisogno G., Scarzello G., Zanetti I., Durante G., Inserra A., Siracusa F., Guglielmi M.; Italian Cooperative Group. Fibrosarcoma in pediatric patients: results of the Italian cooperative group studies (1979–1995). J Surg Oncol 2001;78:225–31. doi: 10.1002/jso.1157.Coffin C.M., Dehner L.P. Soft tissue tumors in first year of life: a report of 190 cases. Pediatr Pathol 1990;10:509–26. doi: 10.3109/15513819009067140.Coffin C.M., Dehner L.P. Soft tissue tumors in first year of life: a report of 190 cases. Pediatr Pathol 1990;10:509–26. doi: 10.3109/15513819009067140.Zeytun H., Okur M.H., Basuguy E., Arslan S., Aydogdu B., Turkcu G., Arslan M.S. Congenital-infantile fibrosarcoma of the ileocecal region: the first case presentation. Pediatr Surg Int 2016;32(1):97–9. doi: 10.1007/s00383-015-3802-0.Zeytun H., Okur M.H., Basuguy E., Arslan S., Aydogdu B., Turkcu G., Arslan M.S. Congenital-infantile fibrosarcoma of the ileocecal region: the first case presentation. Pediatr Surg Int 2016;32(1):97–9. doi: 10.1007/s00383-015-3802-0.Gurney J.G., Young J.L., Roffers S.D., Smith M.A., Bunin G.R. Soft tissue sarcomas. In: Gloecker Ries I.A., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R., eds. SEER pediatric monograph: cancer incidence and survival among children and adolescents, United States SEER program 1975–1995. National Cancer Institute, Bethesda, 1999. Pp. 111–124.Gurney J.G., Young J.L., Roffers S.D., Smith M.A., Bunin G.R. Soft tissue sarcomas. In: Gloecker Ries I.A., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R., eds. SEER pediatric monograph: cancer incidence and survival among children and adolescents, United States SEER program 1975–1995. National Cancer Institute, Bethesda, 1999. Pp. 111–124.Parida L., Fernandez-Pineda I., Uffman J.K., Davidoff A.M., Krasin M.J., Pappo A., Rao B.N. Clinical management of infantile fibrosarcoma: a retrospective single-institution review. Pediatr Surg Int 2013;29(7):703–8. doi: 10.1007/s00383-013-3326-4.Parida L., Fernandez-Pineda I., Uffman J.K., Davidoff A.M., Krasin M.J., Pappo A., Rao B.N. Clinical management of infantile fibrosarcoma: a retrospective single-institution review. Pediatr Surg Int 2013;29(7):703–8. doi: 10.1007/s00383-013-3326-4.Сагоян Г.Б., Качанов Д.Ю., Курникова М.А., Сулейманова А.М., Большаков Н.А., Рощин В.Ю., Терещенко Г.В., Пшонкин А.В., Шаманская Т.В., Варфоломеева С.Р. Ранняя диагностика мышечной дистрофии Дюшенна у ребенка с врожденной инфантильной фибросаркомой мягких тканей правого плеча. Педиатрия. Журнал им. Г.Н. Сперанского 2019;98(4):275–81. doi: 10.24110/0031-403X-2019-98-4-281.Sagoyan G.B., Kachanov D.Yu., Kurnikova M.A., Suleymanova A.M., Bolshakov N.A., Roshchin V.Yu., Tereshchenko G.V., Pshonkin A.V., Shamanskaya T.V., Varfolomeeva S.R. Early diagnosis of Duchenne muscular dystrophy in a child with congenital infantile fibrosarcoma of right shoulder soft tissues. Pediatriya. Zhurnal im. G.N. Speranskogo = Pediatria. Journal named after G.N. Speransky 2019;98(4):275–81. (In Russ.) doi: 10.24110/0031-403X-2019-98-4-281.Ferguson W.S. Advances in the adjuvant treatment of infantile fibrosarcoma. Exp Rev Anticancer Ther 2003;3:185–91. doi: 10.1586/14737140.3.2.185.Ferguson W.S. Advances in the adjuvant treatment of infantile fibrosarcoma. Exp Rev Anticancer Ther 2003;3:185–91. doi: 10.1586/14737140.3.2.185.Coffin C.M., Dehner L.P. Fibroblastic-myofibroblastic tumors in children and adolescents clinicopathologic study of 108 examples in 222 patients. Pediatr Pathol 1991;11(4):569–88. doi: 10.3109/15513819109064791.Coffin C.M., Dehner L.P. Fibroblastic-myofibroblastic tumors in children and adolescents clinicopathologic study of 108 examples in 222 patients. Pediatr Pathol 1991;11(4):569–88. doi: 10.3109/15513819109064791.Lagree M., Toutain F., Revillon Y., Gaussin G., Marie-Cardine A., Lemoine F., Vannier J.P. Recurrent and metastatic infantile fibrosarcoma: a case report. Arch Pediatr 2011;18(1):28–32. doi: 10.1016/j.arcped.2010.10.004.Lagree M., Toutain F., Revillon Y., Gaussin G., Marie-Cardine A., Lemoine F., Vannier J.P. Recurrent and metastatic infantile fibrosarcoma: a case report. Arch Pediatr 2011;18(1):28–32. doi: 10.1016/j.arcped.2010.10.004.Pandey A., Kureel S.N., Bappavad R.P. Chest Wall Infantile Fibrosarcomas – A Rare Presentation. Indian J Surg Oncol 2016;7(1):127–9. doi: 10.1007/s13193-016-0487-3.Pandey A., Kureel S.N., Bappavad R.P. Chest Wall Infantile Fibrosarcomas – A Rare Presentation. Indian J Surg Oncol 2016;7(1):127–9. doi: 10.1007/s13193-016-0487-3.van Grotel M., Blanco E., Sebire N.J., Slater O., Chowdhury T., Anderson J. Distant metastatic spread of molecularly proven infantile fibrosarcoma of the chest in a 2-month-old girl: case report and review of literature. J Pediatr Hematol Oncol 2014;36(3):231–3. doi: 10.1097/MPH.0000000000000055.van Grotel M., Blanco E., Sebire N.J., Slater O., Chowdhury T., Anderson J. Distant metastatic spread of molecularly proven infantile fibrosarcoma of the chest in a 2-month-old girl: case report and review of literature. J Pediatr Hematol Oncol 2014;36(3):231–3. doi: 10.1097/MPH.0000000000000055.Shamberger R.C., Grier H.E., Weinstein H.J., Perez-Atayde A.R., Tarbell N.J. Chest wall tumors in infancy and childhood. Cancer 1989;63(4):774–85. doi: 10.1002/1097-0142(19890215)63:4<774::aid-cncr2820630429>3.0.co;2-2.Shamberger R.C., Grier H.E., Weinstein H.J., Perez-Atayde A.R., Tarbell N.J. Chest wall tumors in infancy and childhood. Cancer 1989;63(4):774–85. doi: 10.1002/1097-0142(19890215)63:4<774::aid-cncr2820630429>3.0.co;2-2.Sultan I., Casanova M., Al-Jumaily U., Meazza C., Rodriguez-Galindo C., Ferrari A. Soft tissue sarcomas in the first year of life. Eur J Cancer 2010;46(13):2449–56. doi: 10.1016/j.ejca.2010.05.002.Sultan I., Casanova M., Al-Jumaily U., Meazza C., Rodriguez-Galindo C., Ferrari A. Soft tissue sarcomas in the first year of life. Eur J Cancer 2010;46(13):2449–56. doi: 10.1016/j.ejca.2010.05.002.Coffin C.M., Fletcher J.A. Infantile fibrosarkoma. In: Fletcher С.D., Unni K.K., Mertens F., eds. WHO classification of tumours. Pathology and Genetics. Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002. Pp. 98–100.Coffin C.M., Fletcher J.A. Infantile fibrosarkoma. In: Fletcher С.D., Unni K.K., Mertens F., eds. WHO classification of tumours. Pathology and Genetics. Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002. Pp. 98–100.Knezevich S.R., McFadden D.E., Tao W., Lim J.F., Sorensen P.H. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998;18(2):184–7. doi: 10.1038/ng0298-184.Knezevich S.R., McFadden D.E., Tao W., Lim J.F., Sorensen P.H. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998;18(2):184–7. doi: 10.1038/ng0298-184.Wegert J., Vokuhl C., Collord G., Del Castillo Velasco-Herrera M., Farndon S.J., Guzzo C., Jorgensen M., Anderson J., Slater O., Duncan C., Bausenwein S., Streitenberger H., Ziegler B., Furtwängler R., Graf N., Stratton M.R., Campbell P.J., Jones D.T., Koelsche C., Pfister S.M., Mifsud W., Sebire N., Sparber-Sauer M., Koscielniak E., Rosenwald A., Gessler M., Behjati S. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun 2018;9(1):2378. doi: 10.1038/s41467-018-04650-6.Wegert J., Vokuhl C., Collord G., Del Castillo Velasco-Herrera M., Farndon S.J., Guzzo C., Jorgensen M., Anderson J., Slater O., Duncan C., Bausenwein S., Streitenberger H., Ziegler B., Furtwängler R., Graf N., Stratton M.R., Campbell P.J., Jones D.T., Koelsche C., Pfister S.M., Mifsud W., Sebire N., Sparber-Sauer M., Koscielniak E., Rosenwald A., Gessler M., Behjati S. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun 2018;9(1):2378. doi: 10.1038/s41467-018-04650-6.Orbach D., Rey A., Ceccheto G., Oberlin O., Casanova M., Thebaud E., Scopinaro M., Bisogno G., Carli M., Ferrari A. Infantile fibrosarcoma: management based on European exrerience. J Clin Oncol 2010;28(2):318–23. doi: 10.1200/JCO.2009.21.9972.Orbach D., Rey A., Ceccheto G., Oberlin O., Casanova M., Thebaud E., Scopinaro M., Bisogno G., Carli M., Ferrari A. Infantile fibrosarcoma: management based on European exrerience. J Clin Oncol 2010;28(2):318–23. doi: 10.1200/JCO.2009.21.9972.Loh M.L., Ahn P., Perez-Atayde A.R., Gebhardt M.C., Shamberger R.C., Grier H.E. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children’s Hospital, Boston. J Pediatr Hematol Oncol 2002;24(9):722–6. doi: 10.1097/00043426-200212000-00008.Loh M.L., Ahn P., Perez-Atayde A.R., Gebhardt M.C., Shamberger R.C., Grier H.E. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children’s Hospital, Boston. J Pediatr Hematol Oncol 2002;24(9):722–6. doi: 10.1097/00043426-200212000-00008.Orbach D., Brennan B., De Paoli A., Gallego S., Mudry P., Francotte N., van Noesel M., Kelsey A., Alaggio R., Ranchère D., De Salvo G.L., Casanova M., Bergeron C., Merks J.H., Jenney M., Stevens M.C., Bisogno G., Ferrari A. Conservative strategy in infantile fibrosarcoma is possible: the European Paediatric Soft Tissue Sarcoma Study Group experience. Eur J Cancer 2016;57:1–9. doi: 10.1016/j.ejca.2015.12.028.Orbach D., Brennan B., De Paoli A., Gallego S., Mudry P., Francotte N., van Noesel M., Kelsey A., Alaggio R., Ranchère D., De Salvo G.L., Casanova M., Bergeron C., Merks J.H., Jenney M., Stevens M.C., Bisogno G., Ferrari A. Conservative strategy in infantile fibrosarcoma is possible: the European Paediatric Soft Tissue Sarcoma Study Group experience. Eur J Cancer 2016;57:1–9. doi: 10.1016/j.ejca.2015.12.028.Sulkowski J.P., Raval M.V., Browne M. Margin status and multimodal therapy in infantile fibrosarcoma. Pediatr Surg Int 2013;8(29):771–6. doi: 10.1007/s00383-013-3318-4.Sulkowski J.P., Raval M.V., Browne M. Margin status and multimodal therapy in infantile fibrosarcoma. Pediatr Surg Int 2013;8(29):771–6. doi: 10.1007/s00383-013-3318-4.Minard-Colin V., Orbach D., Martelli H., Bodemer C., Oberlin O. Soft tissuetumors in neonates. Arch Pediatr 2009;16(7):1039–48. doi: 10.1016/j.arcped.2009.03.005.Minard-Colin V., Orbach D., Martelli H., Bodemer C., Oberlin O. Soft tissuetumors in neonates. Arch Pediatr 2009;16(7):1039–48. doi: 10.1016/j.arcped.2009.03.005.Hyman D.M., Taylor B.S., Baselga J. Implementing genomic-driven oncology. Cell 2017;168(2):584–99. doi: 10.1016/j.cell.2016.12.015.Hyman D.M., Taylor B.S., Baselga J. Implementing genomic-driven oncology. Cell 2017;168(2):584–99. doi: 10.1016/j.cell.2016.12.015.Garber K. In a maior shift, cancer drugs go “tissue-agnostic”. Science 2017;356(6343):1111–2. doi: 10.1126/science.356.6343.1111.Garber K. In a maior shift, cancer drugs go “tissue-agnostic”. Science 2017;356(6343):1111–2. doi: 10.1126/science.356.6343.1111.Laetsch T.W., DuBois S.G., Mascarenhas L., Turpin B., Federman N., Albert C.M., Nagasubramanian R., Davis J.L., Rudzinski E., Feraco A.M., Tuch B.B., Ebata K.T., Reynolds M., Smith S., Cruickshank S., Cox M.C., Pappo A.S., Hawkins D.S. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol 2018;19(5):705–14. doi: 10.1016/S1470-2045(18)30119-0.Laetsch T.W., DuBois S.G., Mascarenhas L., Turpin B., Federman N., Albert C.M., Nagasubramanian R., Davis J.L., Rudzinski E., Feraco A.M., Tuch B.B., Ebata K.T., Reynolds M., Smith S., Cruickshank S., Cox M.C., Pappo A.S., Hawkins D.S. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol 2018;19(5):705–14. doi: 10.1016/S1470-2045(18)30119-0.Drilon A., Laetsch T.W., Kummar S., DuBois S.G., Lassen U.N., Demetri G.D., Nathenson M., Doebele R.C., Farago A.F., Pappo A.S., Turpin B., Dowlati A., Brose M.S., Mascarenhas L., Federman N., Berlin J., El-Deiry W.S., Baik C., Deeken J., Boni V., Nagasubramanian R., Taylor M., Rudzinski E.R., Meric-Bernstam F., Sohal D.P.S., Ma P.C., Raez L.E., Hechtman J.F., Benayed R., Ladanyi M., Tuch B.B., Ebata K., Cruickshank S., Ku N.C., Cox M.C., Hawkins D.S., Hong D.S., Hyman D.M. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med 2018;378(8):731–9. doi: 10.1056/NEJMoa1714448.Drilon A., Laetsch T.W., Kummar S., DuBois S.G., Lassen U.N., Demetri G.D., Nathenson M., Doebele R.C., Farago A.F., Pappo A.S., Turpin B., Dowlati A., Brose M.S., Mascarenhas L., Federman N., Berlin J., El-Deiry W.S., Baik C., Deeken J., Boni V., Nagasubramanian R., Taylor M., Rudzinski E.R., Meric-Bernstam F., Sohal D.P.S., Ma P.C., Raez L.E., Hechtman J.F., Benayed R., Ladanyi M., Tuch B.B., Ebata K., Cruickshank S., Ku N.C., Cox M.C., Hawkins D.S., Hong D.S., Hyman D.M. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med 2018;378(8):731–9. doi: 10.1056/NEJMoa1714448.Berger S., Nartens U.M., Bochum S. Larotrectinib (LOXO-101). Rec Res Cancer Res 2018;211:141–51. doi: 10.1007/978-3-319-91442-8_10.Berger S., Nartens U.M., Bochum S. Larotrectinib (LOXO-101). Rec Res Cancer Res 2018;211:141–51. doi: 10.1007/978-3-319-91442-8_10.

The authors declare that there are no conflicts of interest present.